A randomized, double-blind, placebo-controlled trial evaluating cysteamine in Huntington's disease.
Verny C, Bachoud-Lévi AC, Durr A, Goizet C, Azulay JP, Simonin C, Tranchant C, Calvas F, Krystkowiak P, Charles P, Youssov K, Scherer C, Prundean A, Olivier A, Reynier P, Saudou F, Maison P, Allain P, von Studnitz E, Bonneau D; CYST-HD Study Group.
Verny C, et al. Among authors: bonneau d.
Mov Disord. 2017 Jun;32(6):932-936. doi: 10.1002/mds.27010. Epub 2017 Apr 24.
Mov Disord. 2017.
PMID: 28436572
Clinical Trial.